To treat or not to treat - Critically ill patients with candiduria

Mycoses

Volumn 51, Issue SUPPL. 2, 2008, Pages 12-24

  Hollenbach, Eike ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Antifungal therapy; Candiduria; ICU; Intensive care unit

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CASPOFUNGIN; CYCLOSPORIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; PLACEBO; VANCOMYCIN; VORICONAZOLE;

ARTIFICIAL VENTILATION; ASPERGILLUS; BLADDER CATHETERIZATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CANDIDIASIS; CANDIDURIA; CENTRAL VENOUS CATHETERIZATION; CHILL; CLINICAL TRIAL; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; CRYPTOCOCCUS; CYSTITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG URINE LEVEL; DRUG USE; FEVER; FUNGAL COLONIZATION; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPOTENSION; HYPOXEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MORTALITY; NEPHROTOXICITY; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TOTAL PARENTERAL NUTRITION; TUBULAR WASTING; URINALYSIS; URINARY TRACT INFECTION; URINARY TRACT MALFORMATION; URINE CULTURE; UROGENITAL TUBERCULOSIS;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; RISK FACTORS; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

CANDIDA;

EID: 47949124738     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01570.x     Document Type: Review

References (116)

1. Kauffman CA, Vazquez JA, Sobel JD et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infec Dis 2000 30 : 14 8.
2. Chakrabarti A, Reddy TCS, Singhi S. Does candiduria predict candidemia? Indian J Med Res 1997 106 : 513 6.
3. Weber DJ, Rutala WA, Samsa GP et al. Relative frequency of nosocomial pathogens at a university hospital during the decade 1980 to 1989. Am J Infect Control 1992 20 : 192 7.
4. Storfer SP, Medoff G, Fraser VJ et al. Candiduria: retrospective review in hospitalized patients. Infect Dis Clin Pract 1994 3 : 23 9.
5. Rivett AG, Perry JA, Cohen J. Urinary candidiasis: a prospective study in hospitalized patients. Urol Res 1986 14 : 183 6.
6. Lundstrom T, Sobel J. Nosocomial candiduria: a review. Clin Infect Dis 2001 32 : 1602 7.
7. Schaberg DR, Culver AH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991 91 (Suppl. 3B 72 4S.
8. Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med 1991 91 [ Suppl. 3B ] : 65 71.
9. Pappas PG, Rex JH, Sobel JD et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004 38 : 161 89.
10. Wise GJ, Silver DA. Fungal infections of genitourinary system. J Urol 1993 149 : 1377 88.
11. Piarroux R, Grenouillet F, Balvay P et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004 32 : 2552 3.
12. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002 34 : 7 14.
13. Alvarez-Lerma F, Nolla-Salas J, Leon C et al. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med 2003 29 : 1069 76.
14. Fisher JF, Chew WH, Shadomy S et al. Urinary tract infections due to Candida albicans. Rev Infect Dis 1982 4 : 1107 18.
15. Gubbins PO, Piscitelli SC, Danziger LH. Candidal urinay tract infections: a comprehensive review of their diagnosis and management. Pharmacotherapy 1993 13 : 110 27.
16. Kauffman CA. Candiduria. Clin Infect Dis 2005 41 (Suppl. 6 S371 6.
17. Fisher JF. Candiduria: when and how to treat it. Curr Infect Dis Rep 2000 2 : 523 30.
18. Ayeni O, Riederer KM, Wilson FM et al. Clinicians' reaction to positive urine culture for Candida organisms. Mycoses 1999 42 : 285 9.
19. Abi-Said D, Anaissie E, Uzun O et al. The epidemiology of hematogenous candidiasis by different Candida species. Clin Infect Dis 1997 24 : 1122 8.
20. Olaechea PM, Palomar M, Leon-Gil C et al. Economic impact of candida colonization and candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 2004 23 : 323 30.
21. Armstrong D. Treatment of opportunistic fungal infections. Clin Infect Dis 1993 16 : 1 9.
22. Nassoura Z, Ivatury RR, Simon RJ et al. Candiduria as early maker of disseminated infection in critically ill surgical patients: the role of fluconazol therapy. J Trauma 1993 35 : 290 5.
23. Fisher JF, Newman CL, Sobel JD. Yeast in the urine: solutions for a budding problem. Clin Infect Dis 1995 20 : 183 9.
24. Sobel JD, Kauffman CA, McKinsey D et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. Clin Infect Dis 2000 30 : 19 24.
25. Flechner SM, McAninch JW. Aspergillosis of the urinary tract: ascending route of infection and evolving patterns of disease. J Urol 1981 125 : 598 601.
26. Byrne R, Hamill RJ, Rodriquez-Barradas MC. Cryptococcuria: case reports and literature review. Infect Dis Clin Pract 1997 6 : 513 8.
27. Febre N, Silva V, Medeiros EAS et al. Microbiological characteristics of yeasts isolated from the urinary tract of intensive care unit patients undergoing urinary catheterization. J Clin Microbiol 1999 37 : 1584 6.
28. Center for Infectious Diseases. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000 28 : 429 48.
29. Passos XS, Sales WS, Maciel PJ et al. Candida colonization in intensive care unit patients' urine. Mem Inst Oswaldo Cruz 2005 100 : 925 8.
30. Knoke M, Schulz K, Bernhardt H. Dynamics of Candida isolations from humans in 1992-1995 in Greifswald, Germany. Mycoses 1997 40 : 105 10.
31. Hollenbach E. Invasive candidiasis in the ICU: evidence-based and on the edge of evidence. Mycosis 2008 51 (Suppl. 2 1 21.
32. Toya SP, Schraufnagel DE, Tzelepis GE. Candiduria in intensive care units: association with heavy colonization and candidaemia. J Hosp Infect 2007 66 : 201 6.
33. Slotman GJ, Shapiro E, Moffa SM. Fungal sepsis: multisite colonization versus fungemia. Am Surg 1994 60 : 107 13.
34. Lehner T. Systemic candidiasis and renal involvement. Lancet 1964 1 : 1414 6.
35. Krause RJ, Matheis H, Wulf K. Fungaemia and funguria after oral administration of Candida albicans. Lancet 1969 1 : 598 9.
36. Trapnell J, Roberts M. Prostatic abscess. Br J Surg 1970 57 : 565 9.
37. Singh CR, Lyttle WF. Cystitis emphysematosa caused by Candida tropicalis. J Urol 1983 130 : 1171 3.
38. Mirdha BR, Sethi S, Banerjee U. Prevalence of fungal species in patients with candiduria. Indian J Med Res 1998 107 : 90 3.
39. Paul N, Mathai E, Abraham OC et al. Emerging microbiological trends in candiduria. Clin Infect Dis 2004 39 : 1743 4.
40. Sobel JD, Vazquez JA. Fungal infections of the urinary tract. World J Urol 1999 17 : 410 4.
41. Hamory BH, Wenzel RP. Hospital-associated candiduria: predisposing factors and review of the literature. J Urol 1978 120 : 444 8.
42. Goldberg PK, Kozinn PJ, Wise GJ et al. Incidence and significance of candiduria. JAMA 1979 241 : 582 4.
43. Paul N, Mathai E, Abraham OC et al. Factors associated with candiduria and related mortality. J Infect 2007 43 : 1 6.
44. Kauffman CA, Tan JS. Torulopsis glabrata renal infection. Am J Med 1974 57 : 217 24.
45. Frye K, Donovan JM, Drach GW. Torulopsis glabrata urinary infections: a review. J Urol 1988 139 : 1245 9.
46. Navarro EE, Almario JS, Schaufele RL et al. Quantitative urine cultures do not reliably detect renal candidiasis in rabbits. J Clin Microbiol 1997 35 : 3292 7.
47. Leu H-S, Huang C-T. Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study. Clin Infect Dis 1995 20 : 1152 7.
48. Fong IW, Cheng PC, Hinton NA. Fungicidal effect of amphotericin B in urine: in vitro study to assess feasibility of bladder washout for localization of site of candiduria. Antimicrob Agents Chemother 1991 35 : 1856 9.
49. Sobel JD. Controversies in the diagnosis of candiduria: what is the critical colony count? Curr Treat Options Infect Dis 2002 4 : 81 3.
50. Wise GJ, Goldberg P, Kozinn PJ. Genitourinary candidiasis: diagnosis and treatment. J Urol 1976 116 : 778 80.
51. Kozinn P, Taschdjian CL, Goldberg PK et al. Advances in the diagnosis of renal candidiasis. J Urol 1978 119 : 184 7.
52. Hall WJ. Study of antibody-coated fungi in patients with funguria and suspected disseminated fungal infections or primary fungal pyelonephritis. J Soc Med 1980 73 : 567 9.
53. Everett ED, Eickhoff TC, Ehret JM. Immunofluorescence of yeast in urine. J Clin Microbiol 1975 2 : 142 3.
54. Harding SA, Merz WG. Evaluation of antibody coating of yeasts in urine as an indicator of the site of urinary tract infection. J Clin Microbiol 1975 2 : 222 5.
55. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med 2006 34 : 857 63.
56. Pittet D, Monod M, Suter P et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994 220 : 751 8.
57. Slotman G, Shapiro E, Moffa S. Fungal sepsis: multisite colonization versus fungemia. Am J Surg 1994 60 : 107 13.
58. Charles PE, Dalle F, Aube H et al. Candida spp. colonisation significance in critically ill medical patients: a prospective study. Intensive Care Med 2005 31 : 393 400.
59. Munoz P, Almudena B, Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents 2000 15 : 83 90.
60. Safran D, Dawson E. The effect of empiric and prophylactic treatment with fluconazole on yeast isolates in a surgical trauma intensive care unit. Arch Surg 1997 132 : 1184 9.
61. Gleason T, May A, Carapelli D et al. Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg 1997 132 : 1197 202.
62. Leon C, Ruiz-Santana S, Saavedra P et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006 34 : 730 7.
63. Ostrosky-Zeichner L, Sable C, Sobel J et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007 26 : 271 6.
64. Nicolle LE. A practical guide to antimicrobial management of complicated urinary tract infection. Drugs Aging 2001 18 : 243 54.
65. Scerpella EG, Alhalel R. An unusual cause of acute renal failure: bilateral ureteral obstruction due to Candida tropicalis fungus balls. Clin Infect Dis 1994 18 : 440 2.
66. Siddique MS, Gayed N, McGuire N et al. Salient features of Candida pyelonephritis in adults. Infect Dis Clin Pract 1992 1 : 239 45.
67. High KP, Quagliarello VJ. Yeast perinephric abscess: report of a case and review. Clin Infect Dis 1992 15 : 128 33.
68. Beland G, Piette Y. Urinary tract candidiasis: report of a case with bilateral ureteral obstruction. Can Med Assoc J 1973 108 : 473 5.
69. Visser D, Monnens L, Feitz W et al. Fungal bezoars as a cause of renal insufficiency in neonates and infants-recommended treatment strategy. Clin Nephrol 1998 49 : 198 201.
70. Seidenfeld SM, LeMaistre CF, Setiawan H et al. Emphysematous pyelonephritis caused by Candida tropicalis. J Infect Dis 1982 146 : 569.
71. Tomashefski JF, Abramowsky CR. Candida-associated renal papillary necrosis. Am J Clin Pathol 1981 75 : 190 4.
72. Gross M, Winkler H, Pitlik S, Weinberger M. Unexpected candidemia complicating ureteroscopy and urinary stenting. Eur J Clin Microbiol Infect Dis 1998 17 : 583 6.
73. Bross J, Talbot GH, Maislin G et al. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 1989 87 : 614 20.
74. Talluri G, Mangone C, Freyle J et al. Polymerase chain reaction used to detect candidaemia in patients with candiduria. Urology 1998 51 : 501 5.
75. Magill SS, Swobodac SM, Johnson EA et al. The association between anatomic site of candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn Microbiol Infect Dis 2006 55 : 293 301.
76. Blumberg HM, Jarvis WR, Soucie JM et al. Risk factors for candidal blood stream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001 33 : 177 86.
77. Binelli CA, Moretti ML, Assis RS et al. Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infect 2006 12 : 538 43.
78. Ahmad S, Khan Z, Mustafa SA, Khan ZU. Epidemiology of candida colonization in an intensive care unit of a teaching hospital in Kuwait. Med Mycol 2003 41 : 487 93.
79. Chen YC, Chang SC, Tai HM et al. Molecular epidemiology of candida colonizing critically ill patients in intensive care units. J Formos Med Assoc 2001 100 : 791 7.
80. Voss A, Hollis RJ, Pfaller MA et al. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994 32 : 975 80.
81. Klempp-Selb B, Rimek D, Kappe R. Karyotyping of Candida albicans and Candida glabrata from patients with candida sepsis. Mycoses 2000 43 : 159 63.
82. Shin JH, Park MR, Song JW et al. Microevolution of Candida albicans strains during catheter-related candidemia. J Clin Microbiol 2004 42 : 4025 31.
83. Dyess DL, Garrison RN, Fry DE. Candida sepsis: implications of polymicrobial bloodborne infection. Arch Surg 1985 120 : 345 8.
84. Ang BS, Telenti A, King B et al. Candidaemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis 1993 17 : 662 6.
85. Neumann PR, Rakower SR. The risk of positive cultures for candida in the critically ill patient. Crit Care Med 1978 6 : 73 6.
86. Jacobs LG. Fungal urinary tract infections in the elderly: treatment guidelines. Drugs Aging 1996 8 : 89 96.
87. Jacobs LG, Skidmore EA, Freeman K et al. Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin Infect Dis 1996 22 : 30 5.
88. Jacobs LG, Skidmore EA, Cardoso LA, Ziv F. Bladder irrigation with amphotericin B for treatment of fungal urinary tract infections. Clin Infect Dis 1994 18 : 313 8.
89. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007 20 : 133 63.
90. Bow EJ, Laverdiere M, Lussier N et al. Antifungal prophylaxis for severely neutropenic chemotherapy recipients-a meta-analysis of randomized-controlled clinical trials. Cancer 2002 94 : 3230 46.
91. Graybill JR, Raad I, Negroni R et al. Posaconazole long-term safety in subjects with invasive fungal infections. 44th ICAAC, Washington, DC 2004 Abs # M-1025.
92. Boucher BA, King SR, Wandschneider HL et al. Fluconazole pharmacokinetics in burn patients. Antimicrob Agents Chemother 1998 42 : 930 3.
93. Ullmann AJ, Sanz MA, Tramarin A et al. Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries. Clin Infect Dis 2006 43 : 29 38.
94. Cornely OA, Vehreschild JJ, Ullmann AJ. Is there a role for polyenes in treating invasive mycoses? Curr Opin Infect Dis 2006 19 : 565 70.
95. Patterson TF. Advances and challenges in management of invasive mycosis. Lancet 2005 366 : 1013 25.
96. Bates DW, Su L, Yu DT et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis 2001 32 : 686 93.
97. Wingard JR, Kubilis P, Lee L et al. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis 1999 29 : 1402 7.
98. Imhof A, Walter RB, Schaffner A. Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study. Clin Infect Dis 2003 36 : 943 51.
99. Peleg AY, Woods ML. Continuous and 4 h infusion of amphotericin B: a comparative study involving high-risk haematology patients. J Antimicrob Chemother 2004 54 : 803 8.
100. Harbarth S, Pestotnik SL, Lloyd JF et al. The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med 2001 111 : 528 34.
101. Barrett JP, Vardulaki KA, Conlon C et al. A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations. Clin Ther 2003 25 : 1295 320.
102. Bowden R, Chandrasekar P, White MH et al. A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2002 35 : 359 66.
103. Augustin J, Raffalli J, Aguero-Rosenfeld M et al. Failure of a lipid amphotericin B preparation to eradicate candiduria: preliminary findings based on three cases. Clin Infect Dis 1999 29 : 686 7.
104. Denning DW. Echinocandin antifungal drugs. Lancet 2003 362 : 1142 51.
105. McCormack PL, Perry CM. Caspofungin: a review of its use in the treatment of fungal infections. Drugs 2005 65 : 2049 68.
106. Sobel JD, Bradshaw SK, Lipka CJ, Kartsonis NA. Caspofungin in the treatment of symptomatic candiduria. Clin Infect Dis 2007 44 : 46 9.
107. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003 36 : 630 7.
108. Krieter P, Flannery B, Musick T et al. Disposition of posaconazole following single-dose oral administration in healthy subjects. Antimicrob Agents Chemother 2004 48 : 3543 51.
109. Fan-Havard P, O'Donovan C, Smith SM et al. Oral fluconazole versus amphotericin B irrigation for treatment of candidal funguria. Clin Infect Dis 1995 21 : 960 5.
110. Wise GJ, Kozinn PJ, Goldberg P. Amphotericin B as a urologic irrigant in the management of noninvasive candiduria. J Urol 1982 128 : 82 4.
111. Schöenbeck J. Studies on Candida infection of the urinary tract and on the antimycotic drug 5-flurocytosine. Scand J Urol Nephrol 1972 11 (Suppl. 1 7 48.
112. Eggimann P, Francioli P, Bille J et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999 26 : 1066 72.
113. Garbino J, Lew DP, Romand JA et al. Prevention of severe candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002 28 : 1708 17.
114. Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992 326 : 845 51.
115. Safdar N, Slattery WR, Knasinski V et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis 2005 40 : 1413 21.
116. Drew RH, Arthur RR, Perfect JR. Is it time to abandon the use of amphotericin B bladder irrigation? Clin Infect Dis 2005 40 : 1465 70.